Pulmonary remodeling in asthma

Journal of Investigational Allergology and Clinical Immunology

Volumn 11, Issue 4, 2001, Pages 220-234

  Lieberman, Phil ^a   Yates, Scott W ^a   Welk, Kevin ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; Basement membrane thickening; Bronchial hyperresponsiveness; Decline in FEV1; Elastosis; Remodeling

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; INTERLEUKIN 5 ANTIBODY; NEDOCROMIL; PLACEBO; TENASCIN;

ASTHMA; ATOPY; BASEMENT MEMBRANE; BRONCHUS HYPERREACTIVITY; CIGARETTE SMOKING; DISEASE DURATION; DISEASE SEVERITY; ELASTOSIS; EXTRACELLULAR MATRIX; FORCED EXPIRATORY VOLUME; HUMAN; LUNG BIOPSY; LUNG FUNCTION; ONSET AGE; REVIEW;

ADRENAL CORTEX HORMONES; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; LUNG; MALE; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0035571601     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (196)

1. Tissue remodeling as a feature of persistent asthma
2. Airway remodeling in asthma
3. The natural history of asthma in adults: The problem of irreversibility
4. Airway remodeling and persistent airway obstruction in asthma
5. Repair mechanisms in asthma
6. Airway remodelling takes place in asthma - What are the clinical implications?
7. Airway wall remodelling: Does it occur and what does it mean?
8. Airways remodelling in asthma: No doubt, no more?
9. Airway remodeling and repair
10. Asthma and airway remodeling in the pediatric population
11. Asthma as an irreversible obstructive airway disease
12. Is asthma a fibrotic disease?
13. Consequences of long-term inflammation
14. The natural history of adult asthma: What do we know?
15. The many faces of airway inflammation
16. Consequences of long-term inflammation
17. Airway remodeling in asthma
18. What causes airway remodelling in asthma?
19. Asthma: A disease remodeling the airways
20. Natural history of chronic asthma and its long-term effects on pulmonary function
21. Predicting the impairment and accelerated decline of lung function - The role of immunoglobulin E
22. The structural and functional consequences of chronic allergic inflammation of the airways
23. Airway wall remodelling in asthma
24. Outcome of asthma: Longitudinal changes in lung function
25. Asthma - From bronchoconstriction to airways inflammation and remodeling
26. Airways obstructive diseases: Pathogenetic mechanisms and natural histories of the disorders
27. 1
28. 1 decline
29. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary-function decline: The normative aging study
30. Longitudinal analyses of airway responsiveness and pulmonary function decline
31. 1 decline in male working populations
32. The relationship between airway responsiveness to histamine and pulmonary function level in a random population sample
33. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years
34. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)
35. 1 decline in older adults: The normative aging study
36. Long-term follow-up of pulmonary function in patients with nasal polyposis
37. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis
38. Nonreversible airflow obstruction in lifelong nonsmokers with moderate to severe asthma
39. Lung function in young adults who had asthma in childhood
40. Decline of lung function in adults with bronchial asthma
41. Factors that affect normal lung function in white Australian adults
42. Rate of decline of lung function in subjects with asthma
43. Effects of asthma on pulmonary function in children. A longitudinal population-based study
44. A prospective study of asthma in a rural community
45. Pulmonary function in adolescents with childhood asthma
46. Asthma from childhood to adult age. A prospective study of twenty subjects with special reference to the clinical course and pulmonary function
47. Pubertal growth curves of ventilatory function: Relationship with childhood respiratory symptoms
48. Follow-up of asthma from childhood to adulthood: Influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood
49. Childhood asthma and adult lung function
50. Extrinsic and intrinsic asthma from childhood to adult age: A ten-year follow-up
51. The natural history of childhood asthma to adult life
52. A prospective study of the natural history of asthma. Remission and relapse rates
53. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population
54. Clinical manifestation, pulmonary function and prognosis in asthmatic children: A comparison between groups with a high and a low serum IgE level
55. The long-term prognosis of childhood asthma in a predominantly rural Swedish county
56. A prospective study on non-IgE-mediated asthma in children
57. Childhood asthma in adult life: A further study at 28 years of age
58. Atopy in subjects with asthma followed to the age of 28 years
59. Influence of a positive family history and associated allergic diseases on the natural course of asthma
60. A ten-year follow-up of 180 adults with bronchial asthma: Factors of importance for the decline in lung function
61. Natural history of bronchial asthma in childhood. A prospective study from birth up to 12-14 years of age
62. A seven-year follow-up study of 343 adults with bronchial asthma
63. Interacting effect of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma
64. Natural history of asthma in childhood - A birth cohort study
65. Allergy in subjects with asthma from childhood to adulthood
66. Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children
67. Prognosis of asthma in children: A cohort study into adulthood
68. Factors in childhood as predictors of asthma in adult life
69. Outcome of childhood asthma in mid-adult life
70. Outcome of wheeze in childhood. Symptoms and pulmonary function 25 years later
71. Five-year changes in airflow obstruction and airway responsiveness in mild to moderate asthma
72. Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma
73. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults
74. Ventilatory function in British adults after asthma or wheezing illness at ages 0-35
75. Adult patients may outgrow their asthma. A 25 year follow-up study
76. Childhood asthma and lung function in mid-adult life
77. A 15-year follow-up of ventilatory function in adults with asthma
78. 1
79. Risk factors for the persistence of respiratory symptoms in childhood asthma
80. Asthma from birth to age 23: Incidence and relation to prior and concurrent atopic disease
81. Asthma and irreversible airflow obstruction
82. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction
83. Airways obstruction in patients with long-term asthma consistent with "irreversible asthma"
84. Longitudinal changes in atopy during a 4-year period: Relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren
85. Effect of atopy on the natural history of symptoms, peak expiratory flow, and bronchial responsiveness in 7- and 8-year-old children with cough and wheeze
86. Skin test reactivity to common aeroallergens and decline of lung function
87. Longitudinal analyses of airway responsiveness and pulmonary function decline
88. A 10 year follow-up of 180 adults with bronchial asthma: Factors important for the decline in lung function. Reply
89. Findings prior to diagnoses of asthma among the elderly in a longitudinal study of a general population sample
90. Asthma and wheezing in the first six years of life
91. The natural history of expiratory volumes. Effect of cigarette smoking and respiratory symptoms
92. Effects of cigarette smoke on lung function in adolescent boys and girls
93. Asthma: From childhood to adulthood
94. The presence of airway reactivity before the development of asthma
95. The influence of age and sex on asthma admissions
96. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function
97. Risk factors for development of asthma in children and adolescents: Findings from a longitudinal population study
98. Non-specific bronchial reactivity and its relationship to the clinical expression of asthma: A longitudinal study
99. 1 in population studies
100. 1 during long-term inhaled corticosteroid treatment
101. Irreversible airflow obstruction. Evolution in asthma
102. The relationship between age and duration of asthma and the presence of persistent obstruction in asthma
103. Airways remodeling is a distinctive feature of asthma and is related to severity of disease
104. Accelerated irreversible decline in lung function in asthmatics
105. Overview of issues in the longitudinal analysis of respiratory data
106. Bronchial hyperreactivity to histamine in allergic and nonallergic asthma, allergic rhinitis and chronic bronchitis
107. Relationship of lung function loss to level of initial function: Correcting for measurement error using the reliability coefficient
108. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates
109. Pulmonary function in asthmatic patients in remission
110. The relationship between longitudinal change in pulmonary function and nonspecific airway responsiveness in children and young adults
111. 1 decline. Preliminary results in a working population
112. 1 in male smokers and examination-smokers
113. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction
114. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. The Normative Aging study
115. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma
116. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission
117. Longitudinal evaluation of the association between pulmonary function and total serum IgE
118. The interaction between immunoglobulin E and smoking in airflow obstruction in the elderly
119. 1 in two cohort studies
120. The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders
121. A reexamination of risk factors for ventilatory impairment
122. Airway subepithelial fibrosis in a murine model of atopic asthma suppression by dexamethasone or anti-interleukin-5 antibody
123. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway
124. Myofibroblasts and subepithelial fibrosis in bronchial asthma
125. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-α
126. Airway remodelling in cough-variant asthma
127. Airway remodeling: Potential contributions of subepithelial fibrosis and airway smooth muscle hypertrophy/hyperplasia to airway narrowing in asthma
128. Inflammatory determinants of asthma severity. Bronchial biopsy findings in it or "early" asthma
129. Elastosis and fragmentation of fibers of the elastic system in fatal asthma
130. Bronchial elastic fibers in normal subjects and asthmatic patients
131. Cytokine production by cell cultures from bronchial subepithelial myofibroblasts
132. Mast cells, eosinophils and fibrosis
133. The lack of distensibility of asthmatic airways
134. Mast cell tryptase stimulates both human dermal fibroblast proliferation and type I collagen production
135. Mast cell tryptase and its role in tissue remodelling
136. Expression of growth factors and remodelling of the airway wall in bronchial asthma
137. β-Hexosaminidases: Potent mitogens of airway smooth muscle
138. Thrombin in the airways of asthmatic patients
139. Epithelial-mesenchymal interactions in the pathogenesis of asthma
140. Prolonged allergen exposure induces structural airway changes in sensitized rats
141. Bronchoalveolar lavage fluid from asthmatic subjects is mitogenic for human airway smooth muscle
142. 1
143. Balance in asthma between matrix metalloproteinases and their inhibitors
144. Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects
145. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics
146. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis
147. Airway remodeling in asthma amplifies heterogeneities in smooth muscle shortening causing hyperresponsiveness
148. Mechanisms involved in airway obstruction: The role of smooth muscle
149. Eosinophilia-induced vascular and airway remodeling and hyperresponsiveness in rat lungs
150. Microvascular remodelling in chronic airway inflammation in mice
151. Bronchial angiogenesis in severe glucocorticoid-dependent asthma
152. Histopathologic features of early and progressive asthma
153. The pathology of asthma: Brief review
154. Airway re-modelling in asthma: Role of airway smooth muscle
155. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics
156. Increased matrix metalloproteinase-9 in the airway after allergen challenge
157. Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways
158. Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma
159. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability
160. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine
161. Extracellular matrix lung inflammation
162. The T cell and the airway's fibrotic response in asthma
163. Increased vascularity of the bronchial mucosa in mild asthma
164. Increased levels of elastase and α-1-antitrypsin in sputum of asthmatic patients
165. Transforming growth factor β1 (TGFβ1) gene expression by eosinophils in asthmatic airway inflammation
166. Tryptase-induced mitogenesis in airway smooth muscle cells
167. Hypothesis: Excessive bronchoconstriction in asthma is due to decreased airway elastance
168. Subepithelial fibrosis in the bronchi of asthmatics
169. Central airways behave more stiffly during forced expiration in patients with asthma
170. Continuous and on demand use of bronchodilators in patients with nonsteroid dependent asthma and chronic bronchitis: Four-year follow-up randomized controlled study
171. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
172. Regular albuterol or nedocromil sodium - Effects on airway subepithelial tenascin in asthma
173. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention
174. Interaction between the growing lung and asthma: Role of early intervention
175. Bronchodilator treatment in moderate asthma or chronic bronchitis: Continuous or on demand? A randomised controlled study
176. Effect of early vs late intervention with inhaled corticosteroids in asthma
177. Remodeling of asthmatic airways by glucocorticosteroids
178. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid
179. The effect of treatment with corticosteroids on asthma airway structure and function
180. Inhaled corticosteroid treatment and extracellular matrix in the airways in asthma
181. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma
182. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma
183. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
184. Changes in inflammatory cells and airway remodeling after beclomethasone dipropionate administration
185. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: A placebo-controlled study
186. 1 in adulthood studied
187. Time course of inflammatory and remodeling events in a murine model of asthma: Effect of steroid treatment
188. The immunopathology of extrinsic (atopic) asthma and intrinsic (nonatopic) asthma: More similarities than differences
189. Long term follow-up of pulmonary function in patients with nasal polyposis
190. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD
191. Computed tomography of the lungs in asthma: Influence of disease severity and etiology
192. Long-term effects of budesonide or nedocromil in children with asthma
193. Clinical control and histopathologic outcome when using airway hyperresponsiveness as an additional guide to long-term treatment
194. Airway mucosal inflammation in occupational asthma induced by toluenediisocyanate